"I would think phase 3 has to be completed to prove BIT225's true efficacy..."
That's a given, but the way I understand it is it takes bigpharma with megabucks to fund this stage of the venture.
Someone put up a very informative interview setting out the development sequence leading up to a drug being successful by getting the attention with a positive phase II result leading to a "deal" - which is where they are at present, as I understand it.
Ann: Letter to Shareholders, page-23
-
- There are more pages in this discussion • 432 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.009(32.1%) |
Mkt cap ! $25.26M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.5¢ | 1.8¢ | $218.7K | 10.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1251177 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 482391 | 1 |
View Market Depth
| Last trade - 10.39am 06/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |